Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedFeb 1, 2023METHOTREXATE INTRAVITREALLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0221-2023Class IITerminatedFeb 1, 2023METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0220-2023Class IITerminatedFeb 1, 2023MAGNESIUM CHLORIDE HEXAHYDRATE-PF- 200MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0219-2023Class IITerminatedFeb 1, 2023LIDOCAINE-PF- 5%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0218-2023Class IITerminatedFeb 1, 2023LEVEMIR-STS- 100U/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0217-2023Class IITerminatedFeb 1, 2023KETAMINE 50MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0216-2023Class IITerminatedFeb 1, 2023HYDROXOCOBALAMIN-PF- 1MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0215-2023Class IITerminatedFeb 1, 2023HEPARIN/LIDO HCL/SODIUM BICARB 100U/2MG/16.8MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0214-2023Class IITerminatedFeb 1, 2023GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 31%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0213-2023Class IITerminatedFeb 1, 2023GLYCERIN STERILE 99% 2ML VIAL and 5ML VIALLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0212-2023Class IITerminatedFeb 1, 2023GLYCERIN 72%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0211-2023Class IITerminatedFeb 1, 2023GLUTATHIONE L REDUCED 100MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0210-2023Class IITerminatedFeb 1, 2023GENTAMICIN BLADDER 0.08MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0209-2023Class IITerminatedFeb 1, 2023FLURBIPROFEN -CORN OIL- 0.04%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0208-2023Class IITerminatedFeb 1, 2023Ethyl Alcohol 95%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0207-2023Class IITerminatedFeb 1, 2023ESTRADIOL CYP/TEST CYP- SS OIL- 2MG/50MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0206-2023Class IITerminatedFeb 1, 2023Estradiol 0.05% OPH SolutionLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0205-2023Class IITerminatedFeb 1, 2023EDETATE DISODIUMLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0204-2023Class IITerminatedFeb 1, 2023Edetate Calcium Disodium 400MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0203-2023Class IITerminatedFeb 1, 2023Dexpanthenol/Pyridoxine/Hydroxocobalamin-PF- 250MG/100MG/1MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0202-2023Class IITerminatedFeb 1, 2023DEXAMETHASONE 16MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0201-2023Class IITerminatedFeb 1, 2023CyclosporineLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0200-2023Class IITerminatedFeb 1, 2023Clindamycin/EDTA Calcium 4.1667MG/0.333MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0199-2023Class IITerminatedFeb 1, 2023CholecalciferolLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0198-2023Class IITerminatedFeb 1, 2023Ceftazidime IntravitrealLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0197-2023Class IITerminatedFeb 1, 2023Buprenorphine HCL 0.9 MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0196-2023Class IITerminatedFeb 1, 2023BSS Plus/Lidocaine Opth 1%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0195-2023Class IITerminatedFeb 1, 2023Atropine sulfate 0.05%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0194-2023Class IITerminatedFeb 1, 2023Apomorphine HCL 2MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0193-2023Class IITerminatedFeb 1, 2023AlbuterolLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0192-2023Class IITerminatedFeb 1, 2023Acetylcysteine 10% Ophthalmic SolutionLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0191-2023Class IITerminatedFeb 1, 20235-Fluorouracil 1%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0190-2023Class IITerminatedFeb 1, 2023Minoxidil 0.75%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0189-2023Class IITerminatedFeb 1, 2023Methylcobalamin 1MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0188-2023Class IITerminatedFeb 1, 2023Hydroxocobalamin 25MG/MLLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0187-2023Class IITerminatedFeb 1, 2023Chlorpheniramine/HyoscyamineLack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0186-2023Class IITerminatedFeb 1, 2023Dutasteride 0.1%Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.Pharmacy Innovations · D-0185-2023Class ITerminatedFeb 1, 2023Vancomycin Hydrochloride for InjectionPresence of Particulate Matter: Glass particulate matter detected in injectable.Pfizer Inc. · D-0184-2023Class ITerminatedFeb 1, 2023Advil Liqui GelsLabeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled backGlaxosmithkline Consumer Healthcare Holdings DBA Haleon · D-0183-2023Class ITerminatedFeb 1, 2023Advil Liqui GelsLabeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled backGlaxosmithkline Consumer Healthcare Holdings DBA Haleon · D-0182-2023